MiMedx Group, Inc. Income Taxes Receivable
MiMedx Group, Inc. (MDXG) had Income Taxes Receivable of $11.30 million as of 2020-09-30, per its 10-Q filed 2020-11-04.
Discontinued › Balance Sheet › Assets
us-gaap:IncomeTaxReceivable · last filed 2020-11-04
- 2020-09-30: Income Taxes Receivable $11.30M.
- 2020-06-30: Income Taxes Receivable $11.30M.
- 2020-03-31: Income Taxes Receivable $11.30M.
| Period end | Income Taxes Receivable |
|---|---|
| 2020-09-30 | $11.30M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $11.30M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $11.30M 10-Q · filed 2020-07-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |